148 related articles for article (PubMed ID: 18805575)
41. Fallopian tube cancer in a BRCA1 mutation carrier: rapid development and failure of screening.
Hébert-Blouin MN; Koufogianis V; Gillett P; Foulkes WD
Am J Obstet Gynecol; 2002 Jan; 186(1):53-4. PubMed ID: 11810084
[TBL] [Abstract][Full Text] [Related]
42. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
Evans DG; Lalloo F; Ashcroft L; Shenton A; Clancy T; Baildam AD; Brain A; Hopwood P; Howell A
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2318-24. PubMed ID: 19661091
[TBL] [Abstract][Full Text] [Related]
43. Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
Kehoe SM; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; D'Angelica M; Jarnagin WR; Barakat RR; Chi DS
Gynecol Oncol; 2009 Mar; 112(3):496-500. PubMed ID: 19091388
[TBL] [Abstract][Full Text] [Related]
44. Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.
Petri AL; Kjaer SK; Christensen IJ; Blaakaer J; Hogdall E; Jeppesen U; Mosgaard BJ; Pagel JD; Stilling L; Thranov I; Hogdall C
Acta Obstet Gynecol Scand; 2009; 88(5):536-42. PubMed ID: 19308749
[TBL] [Abstract][Full Text] [Related]
45. Three synchronous primary pelvic cancers--a case report.
Căpîlna ME; Rusu SC; Laczko C; Szabo B; Marian C
Eur J Gynaecol Oncol; 2015; 36(2):216-8. PubMed ID: 26050365
[TBL] [Abstract][Full Text] [Related]
46. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
Matulonis UA; Krag KJ; Krasner CN; Atkinson T; Horowitz NS; Lee H; Penson RT
Gynecol Oncol; 2009 Feb; 112(2):394-9. PubMed ID: 19058838
[TBL] [Abstract][Full Text] [Related]
47. Primary adenocarcinoma of fallopian tube--a case report.
Kalyani R; Kumar ML; Srikantia SH
Indian J Pathol Microbiol; 2005 Apr; 48(2):219-21. PubMed ID: 16758673
[TBL] [Abstract][Full Text] [Related]
48. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
[TBL] [Abstract][Full Text] [Related]
49. Synchronous granulosa cell tumour of the ovary and fallopian tube adenocarcinoma: two rare gynaecological malignancies.
Daskalakis M; de Bree E; Giannikaki E; Tsousis S; Tsiftsis DD
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):558-9. PubMed ID: 17116067
[No Abstract] [Full Text] [Related]
50. Bilateral primary carcinoma of the Fallopian tubes.
Khanna S; Mehrotra ML; Sharma D
J Indian Med Assoc; 1976 May; 66(10):239-41. PubMed ID: 977962
[No Abstract] [Full Text] [Related]
51. Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome.
Lynch HT; Casey MJ
Nat Clin Pract Oncol; 2007 Dec; 4(12):672-3. PubMed ID: 17971803
[No Abstract] [Full Text] [Related]
52. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
53. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
Lan C; Li Y; Liu J
Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
[TBL] [Abstract][Full Text] [Related]
54. [Carcinoma of the Fallopian tube: a case].
Marcos Sánchez F; Sánchez Díaz E; Marrupe González D; Albo Castaño MI; Viana Alonso A; Juárez Ucelay F
An Med Interna; 2006 Feb; 23(2):83-5. PubMed ID: 16566658
[TBL] [Abstract][Full Text] [Related]
55. [Cytogenetic study of a primary carcinoma of the fallopian tube].
Curcio S
Arch Ostet Ginecol; 1966; 71(4):450-6. PubMed ID: 5998099
[No Abstract] [Full Text] [Related]
56. [On the problem of primary cancer of the fallopian tubes].
Vladimirova VS; D'iakonova NK
Pediatr Akus Ginekol; 1967; 2():61. PubMed ID: 5610535
[No Abstract] [Full Text] [Related]
57. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
58. Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer.
Morak M; Laner A; Scholz M; Madorf T; Holinski-Feder E
Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1101-5. PubMed ID: 19047842
[TBL] [Abstract][Full Text] [Related]
59. Clinical and histopathological features of remnant gastric cancers, after gastrectomy for synchronous multiple gastric cancers.
Fujita T; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T
J Surg Oncol; 2009 Nov; 100(6):466-71. PubMed ID: 19653259
[TBL] [Abstract][Full Text] [Related]
60. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma.
Garg K; Soslow RA
J Clin Pathol; 2009 Aug; 62(8):679-84. PubMed ID: 19638537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
